Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$28 Mln
P/E Ratio
--
P/B Ratio
0.3
Industry P/E
--
Debt to Equity
1.09
ROE
-0.91 %
ROCE
-54.77 %
Div. Yield
0 %
Book Value
1.29
EPS
-1.97
CFO
$-385.62 Mln
EBITDA
$-558.99 Mln
Net Profit
$-546.01 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Generation Bio Co (GBIO)
| -57.51 | -10.48 | -52.87 | -83.97 | -59.30 | -- | -- |
|
BSE Sensex*
| 1.99 | 3.77 | 4.29 | 8.22 | 11.74 | 20.16 | 11.15 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
Generation Bio Co (GBIO)
| -35.53 | -58.02 | -44.49 | -75.03 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 36.78 | 9,808.03 | 20.22 | 23.13 | |
| 290.25 | 8,956.09 | 22.08 | 58.42 | |
| 26.54 | 9,559.25 | -- | -28.77 | |
| 103.22 | 10,030.35 | 30.81 | 14.16 |
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid... nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142 Read more
President, CEO & Director
Dr. Cameron Geoffrey McDonough M.D.
President, CEO & Director
Dr. Cameron Geoffrey McDonough M.D.
Headquarters
Cambridge, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Generation Bio Co (GBIO) stood at $ 231 Mln as on 31-Dec-24
The share price of Generation Bio Co (GBIO) is $0.45 (NASDAQ) as of 23-Apr-2025 16:00 EDT. Generation Bio Co (GBIO) has given a return of -59.3% in the last 3 years.
Generation Bio Co (GBIO) has a market capitalisation of $ 28 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Generation Bio Co (GBIO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Generation Bio Co (GBIO) and enter the required number of quantities and click on buy to purchase the shares of Generation Bio Co (GBIO).
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142
The CEO & director of Dr. Cameron Geoffrey McDonough M.D.. is Generation Bio Co (GBIO), and CFO & Sr. VP is Dr. Cameron Geoffrey McDonough M.D..
There is no promoter pledging in Generation Bio Co (GBIO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,012
|
|
|
990
|
|
|
974
|
|
|
896
|
| Generation Bio Co (GBIO) | Ratios |
|---|---|
|
Return on equity(%)
|
-91.02
|
|
Operating margin(%)
|
-398.11
|
|
Net Margin(%)
|
-661.91
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Generation Bio Co (GBIO) was $0 Mln.
$0.04
(
